| Market revenue in 2024 | USD 5.0 million |
| Market revenue in 2030 | USD 11.1 million |
| Growth rate | 14.7% (CAGR from 2025 to 2030) |
| Largest segment | Imaging-based technologies |
| Fastest growing segment | Sequencing-based Technologies |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Imaging-based Technologies, Mass Spectrometry-based Technologies, Sequencing-based Technologies, Other technologies |
| Key market players worldwide | 10x Genomics Inc Ordinary Shares - Class A, Bruker Corp, Fluidigm Corporation, NanoString Technologies, Akoya Biosciences, PerkinElmer, Danaher Corp, S2 Genomics, Seven Bridges |
Publish Date: Mar 11, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Fluidigm Corporation | View profile | 501-1000 | South San Francisco, California, United States, North America | www.fluidigm.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | www.nanostring.com |
| Seven Bridges | View profile | 251-500 | Charlestown, Massachusetts, United States, North America | www.sevenbridges.com/ |
| S2 Genomics | View profile | 11-50 | Livermore, California, United States, North America | s2genomics.com |
| Akoya Biosciences | View profile | 251-500 | Marlborough, Massachusetts, United States, North America | www.akoyabio.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Spatial Proteomics Market Outlook will help companies and investors design strategic landscapes.
Imaging-Based Technologies was the largest segment with a revenue share of 42.0% in 2024.
Horizon Databook has segmented the China spatial proteomics market based on imaging-based technologies, mass spectrometry-based technologies, sequencing-based technologies, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China Spatial Proteomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Spatial Proteomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
